LakeShore Biopharma Co., Ltd (LSB)
NASDAQ: LSB · IEX Real-Time Price · USD
0.490
-0.010 (-2.02%)
At close: Jul 19, 2024, 4:00 PM
0.410
-0.080 (-16.31%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
LakeShore Biopharma Statistics
Total Valuation
LSB has a market cap or net worth of $92.26 million. The enterprise value is $138.41 million.
Market Cap | 92.26M |
Enterprise Value | 138.41M |
Important Dates
The next estimated earnings date is Tuesday, August 13, 2024, after market close.
Earnings Date | Aug 13, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
LSB has 188.33 million shares outstanding. The number of shares has increased by 50.62% in one year.
Shares Outstanding | 188.33M |
Shares Change (YoY) | +50.62% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | 0.13 |
PB Ratio | 1.41 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.94, with a Debt / Equity ratio of 1.18.
Current Ratio | 0.94 |
Quick Ratio | 0.71 |
Debt / Equity | 1.18 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | 773 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -63.97% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -63.97% |
50-Day Moving Average | 0.73 |
200-Day Moving Average | 0.63 |
Relative Strength Index (RSI) | 40.30 |
Average Volume (20 Days) | 27,539 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | n/a |
Pretax Income | n/a |
Net Income | n/a |
EBITDA | n/a |
EBIT | n/a |
Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has $30.62 million in cash and $76.77 million in debt, giving a net cash position of -$46.15 million or -$0.25 per share.
Cash & Cash Equivalents | 30.62M |
Total Debt | 76.77M |
Net Cash | -46.15M |
Net Cash Per Share | -$0.25 |
Equity (Book Value) | 65.27M |
Book Value Per Share | 0.35 |
Working Capital | -7.74M |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
LSB does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -50.62% |
Shareholder Yield | -50.62% |
Earnings Yield | n/a |
FCF Yield | n/a |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | -10.91% |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |